Abstract

Due to the increasing reports of carbapenemase-producing Enterobacteriaceae (CPE) from livestock in recent years, the European Reference Laboratory for Antimicrobial Resistances (EURL-AR) provided a protocol for their recovery from caecum and meat samples. This procedure exhibited limitations for the detection of CPE with low carbapenem MIC values. Therefore, it was modified by a second, selective enrichment in lysogeny broth with cefotaxime (CTX 1 mg/L) and with meropenem (MEM 0.125 mg/L) at 37 °C under microaerophilic conditions. By Real-time PCR, these enrichments are pre-screened for the most common carbapenemase genes. Another adaptation was the use of in-house prepared MacConkey agar with MEM and MEM+CTX instead of commercial selective agar. According to the EURL-method, we achieved 100% sensitivity and specificity using the in-house media instead of commercial agar, which decreased the sensitivity to ~75%. Comparing the method with and without the second enrichment, no substantial influence on sensitivity and specificity was detected. Nevertheless, this enrichment has simplified the CPE-isolation regarding the accompanying microbiota and the separation of putative colonies. In conclusion, the sensitivity of the method can be increased with slight modifications.

Highlights

  • The World Health Organization defines carbapenems as ‘High Priority Critically Important Antimicrobials’ for human medicine [1]

  • Modification of the EURL-Protocol for Isolation of CP E. coli from Caeca Samples

  • In order to determine the number of bacteria that survived the prevailing condition in the pig feces, the recovery rate of the bacteria in feces was determined after storage at 6 ◦ C

Read more

Summary

Introduction

The World Health Organization defines carbapenems as ‘High Priority Critically Important Antimicrobials’ for human medicine [1]. This is due to their role in the treatment of severe human infections with multidrug-resistant bacteria. In European countries carbapenems are not licensed for use in veterinary medicine. Carbapenems may be used in specific circumstances in companion animals [2,3]. An increasing number of carbapenem resistant enterobacteria, including carbapenemaseproducers, have been reported [4]. The reports are limited to human medicine [4,5,6] as carbapenem-resistant bacteria

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.